Thus, we believe that the development of NASH in eNOS-/- mice might be due to the increase in hepatic de novo lipogenesis as a result of the excess lipolysis in adipose tissue. The gene discussed is NOS3; the disease is metabolic dysfunction-associated steatohepatitis.